chr7-128957259-CG-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_012470.4(TNPO3):c.2767del(p.Arg923AspfsTer17) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
TNPO3
NM_012470.4 frameshift
NM_012470.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.14
Genes affected
TNPO3 (HGNC:17103): (transportin 3) The protein encoded by this gene is a nuclear import receptor for serine/arginine-rich (SR) proteins such as the splicing factors SFRS1 and SFRS2. The encoded protein has also been shown to be involved in HIV-1 infection, apparently through interaction with the HIV-1 capsid protein. Several protein-coding and non-coding transcript variants have been found for this gene. [provided by RefSeq, Apr 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0018 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-128957259-CG-C is Pathogenic according to our data. Variant chr7-128957259-CG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 591000.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNPO3 | NM_012470.4 | c.2767del | p.Arg923AspfsTer17 | frameshift_variant | 22/23 | ENST00000265388.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNPO3 | ENST00000265388.10 | c.2767del | p.Arg923AspfsTer17 | frameshift_variant | 22/23 | 1 | NM_012470.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Autosomal dominant limb-girdle muscular dystrophy type 1F Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 09, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant results in an extension of the TNPO3 protein. Other variant(s) that result in a similarly extended protein product (p.*924Cysext*15) have been determined to be pathogenic (PMID: 23543484, 23667635). This suggests that these extensions are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 591000). This frameshift has been observed in at least one individual who was not affected with TNPO3-related conditions (Invitae). This frameshift has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 31071488, 31217819). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the TNPO3 gene (p.Arg923Aspfs*17). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1 amino acid(s) of the TNPO3 protein and extend the protein by 15 additional amino acid residues. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Department of Medical Genetics, University of Pecs | Sep 10, 2018 | The c.2767delC (p.Arg923Aspfs*17) variant was predicted to cause truncated protein. Other dominant truncating mutations in the TNPO3 protein are reported to cause Limb-Girdle Muscular Dystrophy type 1F (LGMD1F) (Gamez J. et al. 2001). Segregation analysis confirmed that the same variant is seen in the patient's affected son, and absent in her unaffected son. The variant has not been previously seen in presumed healthy control databases (ExAC, 1000Genomes, EVS). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at